The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases
- 1 January 2020
- book chapter
- Published by Elsevier
- Vol. 154, 345-391
Abstract
No abstract availableKeywords
This publication has 271 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during ApoptosisImmunity, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary cultureCell Death & Disease, 2011
- β-Cell Loss and β-Cell Apoptosis in Human Type 2 Diabetes Are Related to Islet Amyloid DepositionThe American Journal of Pathology, 2011
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesNature Immunology, 2010
- Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s diseaseBrain, Behavior, and Immunity, 2009
- Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosisDiabetologia, 2009
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007